Sergio
Ruiz Llorente
Profesor/a Ayudante Doctor/a
Publicacións (33) Publicacións de Sergio Ruiz Llorente
2024
-
Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study
Clinical and Translational Oncology
-
Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer
The Journal of clinical investigation, Vol. 134, Núm. 10
2023
-
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
Frontiers in Immunology, Vol. 14
2022
-
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Virchows Archiv, Vol. 480, Núm. 4, pp. 855-871
-
MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer
Clinical and Translational Oncology, Vol. 24, Núm. 12, pp. 2432-2440
-
Multivariate feature selection and autoencoder embeddings of ovarian cancer clinical and genetic data
Expert Systems with Applications, Vol. 206
2021
-
A Resampling Univariate Analysis Approach to Ovarian Cancer from Clinical and Genetic Data
IEEE Access, Vol. 9, pp. 25959-25972
-
Text Analytics and Mixed Feature Extraction in Ovarian Cancer Clinical and Genetic Data
IEEE Access, Vol. 9, pp. 58034-58051
2019
-
CREBBP/EP300 bromodomain inhibition affects the proliferation of AR-positive breast cancer cell lines
Molecular Cancer Research, Vol. 17, Núm. 3, pp. 720-730
2018
-
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation
Epigenetics and Chromatin, Vol. 11, Núm. 1
2017
-
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene
Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 25, pp. E4951-E4960
2016
2013
-
An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer Susceptibility
PLoS ONE, Vol. 8, Núm. 9
-
Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF -mutant thyroid carcinomas
Cancer Discovery, Vol. 3, Núm. 5, pp. 520-533
2012
-
Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line
Nuclear Medicine and Biology, Vol. 39, Núm. 8, pp. 1275-1280
-
Genome-wide analysis of Pax8 binding provides new insights into thyroid functions
BMC Genomics, Vol. 13, Núm. 1
2009
2007
-
Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma
Cancer Research, Vol. 67, Núm. 19, pp. 9561-9567
-
Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients
Human Mutation, Vol. 28, Núm. 6, pp. 613-621
2006
-
Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: A possible hot spot?
Genes Chromosomes and Cancer, Vol. 45, Núm. 3, pp. 213-219